COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Retrospective of Children With ADHD and Cardiac Symptoms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00266955
Recruitment Status : Terminated (insufficient number of eligible subjects)
First Posted : December 20, 2005
Last Update Posted : July 6, 2011
Information provided by:
Children's Healthcare of Atlanta

Brief Summary:
There is some evidence suggesting ADHD medication interaction could result in mild myocardial ischemia/infarct.

Condition or disease
Congenital Disorders

Detailed Description:

Children with no previous cardiac history who have been on Adderall for ADHD, have developed acute cardiac symptoms after the addition of Straterra for the treatment of ADHD.

We wish to do a study of the medication interactions of Straterra and other ADHD medications focusing on the cardiac manifestations.

We will collect the following information on each patient: Medical Record Number, Account number, Dates of Admission, Discharge, Treatment or Death, Information Regarding Cardiac Signs and Symptoms, Medication Information, Age, Weight, Diagnoses

Layout table for study information
Study Type : Observational
Actual Enrollment : 10 participants
Time Perspective: Retrospective
Official Title: A Retrospective Study of Children With ADHD and Cardiac Symptoms
Study Start Date : January 1999
Actual Study Completion Date : September 2007

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
retro chart review

Inclusion Criteria:

  • ADHD
  • myocardial ischemia/infarct
  • no previous cardiac history
  • added Straterra
  • already taking Adderall

Exclusion Criteria:

  • those who do not meet inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00266955

Layout table for location information
United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Children's Healthcare of Atlanta
Layout table for investigator information
Principal Investigator: Martha Clabby, MD Children's Healthcare of Atlanta
Layout table for additonal information Identifier: NCT00266955    
Other Study ID Numbers: 04-111
First Posted: December 20, 2005    Key Record Dates
Last Update Posted: July 6, 2011
Last Verified: September 2007
Keywords provided by Children's Healthcare of Atlanta: